Volume 108, Issue 4 pp. 729-736

Mastocytosis cells bearing a c-kit activating point mutation are characterized by hypersensitivity to stem cell factor and increased apoptosis

Yigal Dror

Yigal Dror

Division of Hematology/Oncology, Department of Pediatrics, Research Institute, The Hospital for Sick Children and the University of Toronto, Toronto, Canada,

Search for more papers by this author
Michael Leaker

Michael Leaker

Division of Hematology/Oncology, Department of Pediatrics, Research Institute, The Hospital for Sick Children and the University of Toronto, Toronto, Canada,

Search for more papers by this author
Georgina Caruana

Georgina Caruana

Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada

Search for more papers by this author
Alan Bernstein

Alan Bernstein

Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada

Search for more papers by this author
Melvin H. Freedman

Melvin H. Freedman

Division of Hematology/Oncology, Department of Pediatrics, Research Institute, The Hospital for Sick Children and the University of Toronto, Toronto, Canada,

Search for more papers by this author
First published: 24 December 2001
Citations: 12
Dr YigalDror Department of Paediatric Haematology/Oncology, Chaim-Sheba Medical Centre, Tel-Hashomer 52621, Israel. E-mail: [email protected]

Abstract

Mastocytosis is characterized by abnormal infiltration of mast cells into various organs. An activating mutation in c-kit, involving an A → T substitution at nucleotide 2648 has recently been described in some patients with mastocytosis. We describe a 12-year-old girl with this mutation in her bone marrow cells at diagnosis with a myelodysplastic syndrome (MDS) without evidence of mastocytosis, and then in peripheral blood mononuclear cells 1 year later after the emergence of mastocytosis. The role of the c-Kit receptor and its ligand stem cell factor (SCF) in the pathogenesis of the disease was analysed in marrow cell clonogenic assays. We show that the genetic abnormalities in the patient resulted in factor-independent growth and hypersensitivity of primitive progenitors to SCF, with increased production of mast cells. Increased apoptosis and cluster formation, consistent with the myelodysplastic nature of the disorder, accompanied accumulation of abnormal cells with increasing concentrations of SCF.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.